ADVISORY/Bausch & Lomb Receives FDA Approval to Market Its Leading Technolas 217 Laser in the United States.News/Assignment Editors ADVISORY...for Thurs. (Feb. 24) --(BUSINESS WIRE) WHAT: Bausch & Lomb will conduct an Investor Relations Investor relations The process by which the corporation communicates with its investors. Conference Call and a Media Briefing Conference Call to discuss the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval of the company's Technolas(R) 217 laser system. The media are invited to be a part of both calls. The Investor Relations Call is accessible to you in a `listen only' mode. You will not be able to ask questions. Any questions you may have can be directed to Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. William William, crown prince of Germany William or Frederick William, 1882–1951, crown prince of Germany, son of William II. In World War I he commanded (1914) an army on the Western Front and was nominal commander in the German attack M. Carpenter and Bausch & Lomb Surgical President Hakan S. Edstrom during the Media Briefing Conference Call immediately following the Investor Relations Call. WHEN: Thursday Thursday: see week. , February February: see month. 24, 2000 Investor Relations Call -- 10:00 a.m., Eastern Standard Time Media Briefing Call -- 11:00 a.m., Eastern Standard Time (Note: The news release will be issued via Business Wire Thursday morning before the New York Stock Exchange New York Stock Exchange (NYSE) World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City. opens. The release will also be faxed to Bausch & Lomb beat reporters once it has cleared the wire.) WHO: Bausch & Lomb Chairman and CEO William M. Carpenter, and Bausch & Lomb Surgical President Hakan S. Edstrom will give brief remarks regarding the Technolas 217 approval and then they will open up the call to questions from Wall Street analysts and investors. Reporters will not be able to ask questions during this call. However, reporters can ask questions during the scheduled Media Briefing. WHY: The media briefing has been set up to allow all interested reporters equal access to the CEO and surgical division president. Since Mr. Carpenter's time is extremely limited, he will only be available to the news media in this forum; his schedule will not allow for one-on-on (/TD)(TD)e interviews. However, there may be an opportunity for additional time with Mr. Edstrom and that will be determined on a case-by-case Adj. 1. case-by-case - separate and distinct from others of the same kind; "mark the individual pages"; "on a case-by-case basis" item-by-item, individual basis. HOW: Investor Relations Call -- DIAL-IN NUMBER: 913/981-4912 Rebroadcast of the investor call is available from at 1:00 p.m., EST, Thursday, February 24, 2000, until midnight, Monday, February 28th. The rebroadcast number is 719/457-0820; confirmation code 913936. Media Briefing -- DIAL-IN NUMBER: 913/981-4912 This will be a two-way call, which, at the appropriate time, will allow you to ask questions of Messrs. Carpenter and Edstrom. This call will not be rebroadcast. To ensure that the conference calls begin on time, please dial in 5 to 10 minutes prior to the appointed ap·point tr.v. ap·point·ed, ap·point·ing, ap·points 1. To select or designate to fill an office or a position: appointed her the chief operating officer of the company. 2. start times. Thank you. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion